| VIRACTA Viracta Therapeutics, Inc.
97457119 14 Jun 2022 | on 09 Apr 2024
| Development of pharmaceutical preparations and medicines; drug discove... Class 005 Class 005 Pharmaceutical Products The color(s) teal and green is/are claimed as a feature of the mark. Class 042 Class 042 Computer & Software Services & Scientific Services Providing medical information, consultancy and advisory services; providing a website via a global computer network featuring medical information in the fields of cancer, viral-associated cancers and other viral associated diseases and disorders Class 044 Medical, Beauty & Agricultural Services Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines in the nature of pharmaceutical research; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of biological and chemical preparations for the treatment of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of pharmaceutical products, preparations and compounds for the treatment of viral-associated cancers and other viral associated diseases and disorders; DNA screening and analysis services for scientific research purposes; research and development of pharmaceutical products, preparations and compounds for T-cell adoptive transfer, immune reconstitution, and cell-based immunotherapy; research and development of pharmaceutical products, preparations and compounds for the treatment of cancer, tumors, and hematological malignancies | | | VIRACTA Viracta Therapeutics, Inc.
90419851 28 Dec 2020 | on 24 May 2022
| pharmaceutical and therapeutic preparations for the treatment of patie... Class 005 Class 005 Pharmaceutical Products pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies | | | VIRACTA Viracta Therapeutics, Inc.
87499368 21 Jun 2017 | on 01 Feb 2021 | pharmaceutical and therapeutic preparations for the treatment of patie... Class 005 Class 005 Pharmaceutical Products pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer | | 
